Author:
Chang Martin C,Malowany Janet I,Mazurkiewicz Julita,Wood Martha
Publisher
Springer Science and Business Media LLC
Subject
Pathology and Forensic Medicine
Reference23 articles.
1. Navolanic PM, Steelman LS, McCubrey JA . EGFR family signaling and its association with breast cancer development and resistance to chemotherapy. Int J Oncol 2003;22:237–252.
2. Slamon DJ, Clark GM, Wong SG, et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987;235:177–182.
3. Pritchard KI, Shepherd LE, O'Malley FP, et al. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N Engl J Med 2006;354:2103–2111.
4. Piccart-Gebhart MJ, Procter M, Leyland-Jones B, et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005;353:1659–1672.
5. Jagiello-Gruszfeld A, Tjulandin S, Dobrovolskaya N, et al. A single-arm phase II trial of first-line paclitaxel in combination with lapatinib in HER2-overexpressing metastatic breast cancer. Oncology 2010;79:129–135.